ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

22,342Medicare Part D Prescriptions Filled, Including Refills

Rank: 29 out of 680

$1.36M Total Retail Price of All Prescriptions

Rank: 32 out of 680

743 Patients Receiving at Least One Drug in Part D
81%Patients 65 Years and Older
54% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Louisiana
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 743 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

19% of this provider’s 743 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

3% of this provider’s 17,767 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$61 was the average price of a prescription from this provider, compared to $59 among peers.

Prescriptions per Patient

30 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Louisiana
LEVOTHYROXINE SODIUM 891 787 1 2
HYDROCODONE-ACETAMINOPHEN 751 499 S3 2 4
SIMVASTATIN 648 541 3 3
GABAPENTIN 623 525 4 15
OMEPRAZOLE 578 474 5 7
METFORMIN HCL 494 401 6 8
AMLODIPINE BESYLATE 401 311 7 1
PREDNISONE 348 262 8 50
PRAVASTATIN SODIUM 344 284 9 10
MELOXICAM 335 247 10 24
TRAMADOL HCL 327 284 11 18
FUROSEMIDE 316 242 12 6
HYDROCHLOROTHIAZIDE 303 256 13 9
NEXIUM 301 213 14 16
CITALOPRAM HBR 296 283 15 22
CYMBALTA 294 176 16 46
NAMENDA 292 292 17 35
METOPROLOL SUCCINATE 285 255 18 13
ATORVASTATIN CALCIUM 269 239 19 11
TRAZODONE HCL 260 183 20 48
CARVEDILOL 249 193 21 23
ZOLPIDEM TARTRATE 235 158 22 17
LISINOPRIL 234 160 23 5
SYNTHROID 224 219 24 38
JANUVIA 222 173 25 60
CIPROFLOXACIN HCL 205 164 26 57
METOPROLOL TARTRATE 203 178 27 12
GLIMEPIRIDE 202 179 28 29
ALENDRONATE SODIUM 198 186 29 32
SERTRALINE HCL 196 146 30 28
QUETIAPINE FUMARATE 189 169 31 64
ENALAPRIL MALEATE 185 169 32 65
LOSARTAN POTASSIUM 179 155 33 21
WARFARIN SODIUM 178 143 34 20
CRESTOR 169 148 35 25
MIRTAZAPINE 163 139 36 78
AMOXICILLIN 151 105 37 111
BENAZEPRIL HCL 142 135 38 40
EVISTA 138 121 39 135
DONEPEZIL HCL 136 132 40 27
OXYBUTYNIN CHLORIDE ER 129 124 41 143
METFORMIN HCL ER 129 110 41 54
SINGULAIR 128 88 43 91
AMLODIPINE BESYLATE-BENAZEPRIL 125 119 44 43
CLOPIDOGREL 118 102 45 26
METOCLOPRAMIDE HCL 117 91 46 118
ROPINIROLE HCL 114 107 47 99
PANTOPRAZOLE SODIUM 114 90 47 30
SPIRONOLACTONE 109 76 49 82
ESCITALOPRAM OXALATE 108 100 50 45
LANTUS SOLOSTAR 108 93 50 84
CLONIDINE HCL 106 61 52 36
DIOVAN HCT 105 60 53 55
OXYCODONE HCL-ACETAMINOPHEN 105 28 S2 53 133
FLUTICASONE PROPIONATE 102 72 55 41
ALLOPURINOL 101 87 56 33
CYCLOBENZAPRINE HCL 100 66 R 57 81
MONTELUKAST SODIUM 98 72 58 157
ADVAIR DISKUS 96 63 59 53
DIOVAN 95 91 60 31
TAMSULOSIN HCL 93 69 61 34
TRIAMTERENE-HCTZ 88 75 62 52
RANITIDINE HCL 87 63 63 56
PLAVIX 85 67 64 39
LANTUS 85 62 64 49
OXYBUTYNIN CHLORIDE 85 85 64 129
POTASSIUM CHLORIDE 81 68 67 14
FENOFIBRATE 76 68 68 66
CELEBREX 76 67 68 90
INSULIN SYRINGE 75 63 70 86
PHENYTOIN SODIUM EXTENDED 74 40 71 115
PROPRANOLOL HCL 74 44 71 145
ZETIA 74 58 71 87
AMITRIPTYLINE HCL 73 67 R 74 47
LOVASTATIN 72 72 75 44
POLYETHYLENE GLYCOL 3350 72 46 75 62
LYRICA 71 50 77 77
LISINOPRIL-HYDROCHLOROTHIAZIDE 70 36 78 37
GLIPIZIDE 67 62 79 63
ATENOLOL 67 56 79 19
ESTRADIOL 66 54 R 81 134
FLUCONAZOLE 66 45 81 139
DIGOXIN 65 62 83 58
PEN NEEDLE 65 52 83 122
KLOR-CON M20 65 61 83 61
SULFAMETHOXAZOLE-TRIMETHOPRIM 64 48 86 94
GEMFIBROZIL 63 59 87 106
BENICAR HCT 62 62 88 150
MEGESTROL ACETATE 61 43 R 89 88
PREMARIN 61 44 R 89 105
FLUOXETINE HCL 60 51 91 74
PROAIR HFA 60 37 91 67
PROMETHAZINE HCL 59 34 R 93 96
OXYCODONE-ACETAMINOPHEN 59 30 S2 93 215
VESICARE 59 56 93 176
DETROL LA 59 49 93 169
RAMIPRIL 58 41 97 69
MECLIZINE HCL 57 46 98 103
AGGRENOX 57 57 98 177
PAROXETINE HCL 55 37 100 76
GLYBURIDE-METFORMIN HCL 54 54 R 101 107
LANSOPRAZOLE 54 54 101 184
AZITHROMYCIN 53 39 103 42
GLIPIZIDE XL 53 46 103 142
TRAMADOL HCL-ACETAMINOPHEN 52 33 105 153
OLANZAPINE 52 41 105 116
ACTOS 51 39 107 114
LIPITOR 50 47 108 68
LOSARTAN-HYDROCHLOROTHIAZIDE 50 45 108 51
ISOSORBIDE MONONITRATE ER 50 42 108 59
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 9, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.